Bastide reports sales of 134.7 ME for the 3rd quarter of its 2023/24 fiscal year, up 8.2% on restated sales for the same period a year earlier.

For the first nine months of the fiscal year, Bastide recorded cumulative sales of ME 395.2, up 7.6%.

This performance includes the contribution of companies acquired within the last year, Oxigo and Occit'perf, for ME 0.6.

Given the strong momentum observed, particularly in the homecare market, the Group confirms its 2023-2024 outlook.

The Bastide Group is thus targeting annual sales of 520 ME (adjusted for perimeter effects) and a current operating margin at least equal to that achieved in the 2022-2023 financial year, i.e. 8.4%.


Copyright (c) 2024 CercleFinance.com. All rights reserved.